To determine whether the compromised antitumor effect of alisertib was due to tumor PD-L1 induction in mouse tumor models, we generated 2 Pdl1–/– CT26 cell lines using the CRISPR/Cas9 system (Supplemental Figure 5A). This evidence concerns the gene CD274 and neoplasm.